Your browser doesn't support javascript.
loading
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
Dodick, David W; Goadsby, Peter J; Schwedt, Todd J; Lipton, Richard B; Liu, Chengcheng; Lu, Kaifeng; Yu, Sung Yun; Severt, Lawrence; Finnegan, Michelle; Trugman, Joel M.
Afiliação
  • Dodick DW; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA; Atria Academy of Science and Medicine, New York, NY, USA. Electronic address: dodick.david@mayo.edu.
  • Goadsby PJ; Department of Neurology, King's College London, London, UK; Department of Neurology, University of California, Los Angeles, CA, USA.
  • Schwedt TJ; Department of Neurology, Mayo Clinic, Phoenix, AZ, USA.
  • Lipton RB; Montefiore Headache Center, Albert Einstein College of Medicine, New York, NY, USA.
  • Liu C; AbbVie, Madison, NJ, USA.
  • Lu K; AbbVie, Madison, NJ, USA.
  • Yu SY; AbbVie, Madison, NJ, USA.
  • Severt L; AbbVie, Madison, NJ, USA.
  • Finnegan M; AbbVie, Madison, NJ, USA.
  • Trugman JM; AbbVie, Madison, NJ, USA.
Lancet ; 402(10419): 2307-2316, 2023 12 16.
Article em En | MEDLINE | ID: mdl-37979595
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Enxaqueca Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtornos de Enxaqueca Limite: Adult / Female / Humans / Male Idioma: En Revista: Lancet Ano de publicação: 2023 Tipo de documento: Article